Neptune Wellness Solutions (Neptune Wellness Solutions) Risk Assessment

View and export this data going back to 2007. Start your Free Trial

What is Neptune Wellness Solutions Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Neptune Wellness Solutions is: No Data: Cannot be evaluated.

Competitive Comparison of Neptune Wellness Solutions's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Neptune Wellness Solutions's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neptune Wellness Solutions's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neptune Wellness Solutions's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Neptune Wellness Solutions's Risk Assessment falls into.

Neptune Wellness Solutions (OTCPK:NEPTF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Neptune Wellness Solutions Risk Assessment Related Terms

Thank you for viewing the detailed overview of Neptune Wellness Solutions's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Neptune Wellness Solutions (Neptune Wellness Solutions) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neptune Wellness Solutions Inc (OTCPK:NEPTF) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

NTU:Germany NTU:Germany

Address

545 Promenade du Centropolis, Suite 100, Laval, QC, CAN, H7T 0A3

Website

https://www.neptunecorp.com

Neptune Wellness Solutions Inc is a consumer-packaged goods company that aims to innovate health and wellness products. It focuses on developing a portfolio of high-quality, affordable consumer products that align with the latest market trends for natural, sustainable, plant-based and purpose-driven lifestyle brands. The company's products are available in more than 27,000 retail locations and include well-known organic food and beverage brands such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. With its efficient and adaptable manufacturing and supply chain infrastructure, the company can quickly respond to consumer demand, and introduce new products through retail partners and e-commerce channels.

Executives

Neptune Securities Settlement Fund	10 percent owner	C/O POMERANTZ LLP, 10 S. LASALLE ST., SUITE 3505, CHICAGO IL 60603
Raymond Silcock	officer: Chief Financial Officer	399 JEFFERSON ROAD, PARSIPPANY NJ 07054
Philip H Sanford	director	C/O CHATTEM INC, 1715 WEST 38TH STREET, CHATTANOOGA TN 37409
John Wirt	officer: See Remarks	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Michael Cammarata	director, officer: See Remarks	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Randy Weaver	officer: Chief Financial Officer	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Jessica Adkins	officer: See Remarks	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Cecil Demorris Brown	officer: See Remarks	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Joseph Buaron	director	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Julie Phillips	director	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Ronald Denis	director	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Emily Fletty	officer: See Remarks	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Geus Michael De	director	100-545 PROMENADE DU CENTROPOLIS, LAVAL A8 H7T0A3
Blumont Capital Corp	10 percent owner	70 UNIVERSITY AVENUE, SUITE 1200, TORONTO A6 M5J 2M4